1.92
Schlusskurs vom Vortag:
$2.08
Offen:
$2.15
24-Stunden-Volumen:
54,505
Relative Volume:
0.12
Marktkapitalisierung:
$5.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.13%
1M Leistung:
-18.64%
6M Leistung:
+1.32%
1J Leistung:
+0.00%
Vivosim Labs Inc Stock (VIVS) Company Profile
Firmenname
Vivosim Labs Inc
Sektor
Branche
Telefon
858-224-1000
Adresse
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Vergleichen Sie VIVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VIVS
Vivosim Labs Inc
|
1.92 | 5.42M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-12-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Eingeleitet | Raymond James | Outperform |
| 2015-08-11 | Herabstufung | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Eingeleitet | Jefferies | Buy |
| 2015-06-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Vivosim Labs Inc Aktie (VIVS) Neueste Nachrichten
VivoSim Labs, Inc.Common Stock (NQ: VIVS - FinancialContent
Why VivoSim Labs Inc. stock is favored by pension fundsJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - ulpravda.ru
Is VivoSim Labs Inc. (4OR) stock prepared for digital transition2025 Historical Comparison & Fast Entry and Exit Trade Plans - ulpravda.ru
How VivoSim Labs Inc. stock compares to market leadersWeekly Profit Summary & High Accuracy Investment Signals - ulpravda.ru
Can VivoSim Labs Inc. stock deliver surprise earnings beatJuly 2025 Spike Watch & Smart Allocation Stock Reports - ulpravda.ru
Is VivoSim Labs Inc. (4OR) stock a top dividend aristocrat candidateRisk Adjusted Returns & Stay Ahead With Daily Market Discussions - ulpravda.ru
VivoSim Labs appoints Amar Sethi as chief scientific officer By Investing.com - Investing.com Nigeria
Why VivoSim Labs Inc. stock could outperform in 20252026 world cup usa national team round of 16 playmakers set piece tactics expert forecast statistical analysis - ulpravda.ru
Is VivoSim Labs Inc. stock affected by interest rate hikes2026 world cup usa national team semifinals defensive leaders high defensive line winner prediction preview - ulpravda.ru
VIVS Insider Trading - Quiver Quantitative
VivoSim Labs appoints Amar Sethi, M.D., Ph.D. as chief scientific officer - MarketScreener
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - The Manila Times
VivoSim Labs appoints Amar Sethi as chief scientific officer - Investing.com
Is VivoSim Labs Inc. stock positioned for long term growth2026 world cup usa national team group stage top scorers high defensive line tactical prediction statistical analysis - ulpravda.ru
Target’s SoHo Store Opens Amid Strategic Expansion Efforts - StocksToTrade
VivoSim Labs (NASDAQ:VIVS) Shares Up 2.6% – Should You Buy? - Defense World
Merger Talk: Why retail investors favor VivoSim Labs Inc. stockMarket Rally & Technical Analysis for Trade Confirmation - Улправда
Why retail investors favor VivoSim Labs Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - Улправда
Earnings Update: Why retail investors favor VivoSim Labs Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - Улправда
US Stocks Recap: Why VivoSim Labs Inc. stock could outperform in 2025Day Trade & Verified Technical Trade Signals - Улправда
Amar Akhtar Sethi Net Worth (2025) - GuruFocus
Trade Recap: Will VivoSim Labs Inc. stock benefit from automationGlobal Markets & High Win Rate Trade Tips - ulpravda.ru
Buyback Watch: Is VivoSim Labs Inc. stock attractive after correctionWeekly Market Report & Stepwise Entry/Exit Trade Alerts - Улправда
VivoSim Labs Stockholders Approve Directors and Governance Matters - TipRanks
Is VivoSim Labs Inc. stock undervalued vs historical averagesJuly 2025 Selloffs & Free Growth Oriented Trading Recommendations - Улправда
Will VivoSim Labs Inc. stock benefit from automationPortfolio Value Summary & Verified Entry Point Detection - Улправда
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser
How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser
What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser
Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser
VivoSim Labs (VIVS) Competitors and Alternatives 2025 - MarketBeat
Will VivoSim Labs Inc. (4OR) stock beat revenue estimatesEarnings Growth Report & Real-Time Volume Analysis - Newser
Will VivoSim Labs Inc. (4OR) stock split increase liquidity - Newser
Momentum Shift: Is VivoSim Labs Inc. stock a safe investment in uncertain marketsWeekly Volume Report & Consistent Growth Stock Picks - moha.gov.vn
VivoSim Labs Inc. (VIVS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is VivoSim Labs Inc. (4OR) stock safe for risk averse investorsJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com
How VivoSim Labs Inc. (4OR) stock reacts to weak economy2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Finanzdaten der Vivosim Labs Inc-Aktie (VIVS)
Es liegen keine Finanzdaten für Vivosim Labs Inc (VIVS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):